David A. Siegel Precigen, Inc. Transaction History

Two Sigma Advisers, LP

$42.8 Billion
Q1 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Precigen, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 81,700 shares of PGEN stock, worth $107,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,700

Previous 92,600 11.77%

Holding current value

$107,844

Previous $103,000 17.48%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.07 - $2.03 $11,663 - $22,126	-10,900 Reduced 11.77%	81,700 $121,000
Q4 2024 Feb 14, 2025	SELL	$0.67 - $1.12 $2,814 - $4,704	-4,200 Reduced 4.34%	92,600 $103,000
Q3 2024 Nov 14, 2024	SELL	$0.91 - $1.88 $13,559 - $28,012	-14,900 Reduced 13.34%	96,800 $91,000
Q2 2024 Aug 14, 2024	BUY	$1.27 - $1.75 $14,859 - $20,475	11,700 Added 11.7%	111,700 $176,000
Q1 2024 May 15, 2024	SELL	$1.21 - $1.75 $726 - $1,050	-600 Reduced 0.6%	100,000 $145,000
Q4 2023 Feb 14, 2024	SELL	$0.89 - $1.41 $4,984 - $7,896	-5,600 Reduced 5.27%	100,600 $134,000
Q3 2023 Nov 14, 2023	SELL	$1.08 - $1.85 $54,864 - $93,980	-50,800 Reduced 32.36%	106,200 $150,000
Q2 2023 Aug 14, 2023	SELL	$0.96 - $1.4 $15,744 - $22,960	-16,400 Reduced 9.46%	157,000 $180,000
Q1 2023 May 15, 2023	SELL	$0.88 - $2.19 $148,113 - $368,601	-168,311 Reduced 49.26%	173,400 $183,000
Q4 2022 Feb 14, 2023	SELL	$1.27 - $2.26 $57,912 - $103,055	-45,600 Reduced 11.77%	341,711 $519,000
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $74,166 - $146,754	-52,600 Reduced 11.96%	387,311 $821,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $2.53 $138,805 - $305,371	-120,700 Reduced 21.53%	439,911 $589,000
Q1 2022 May 16, 2022	BUY	$1.91 - $3.98 $462,984 - $964,752	242,400 Added 76.18%	560,611 $1.18 Million
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $210,741 - $328,350	59,700 Added 23.09%	318,211 $1.18 Million
Q3 2021 Nov 15, 2021	SELL	$4.99 - $6.55 $601,295 - $789,275	-120,500 Reduced 31.79%	258,511 $1.29 Million
Q2 2021 Aug 16, 2021	SELL	$6.24 - $8.22 $1.45 Million - $1.91 Million	-232,000 Reduced 37.97%	379,011 $2.47 Million
Q1 2021 May 17, 2021	BUY	$6.74 - $10.95 $2.62 Million - $4.25 Million	388,400 Added 174.47%	611,011 $4.21 Million
Q4 2020 Feb 16, 2021	BUY	$3.75 - $10.56 $116,250 - $327,360	31,000 Added 16.18%	222,611 $2.27 Million
Q3 2020 Nov 16, 2020	BUY	$3.5 - $6.2 $50,750 - $89,900	14,500 Added 8.19%	191,611 $671,000
Q2 2020 Aug 14, 2020	BUY	$2.16 - $5.46 $181,008 - $457,548	83,800 Added 89.81%	177,111 $884,000
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $136,234 - $670,906	93,311 New	93,311 $317,000

Others Institutions Holding PGEN

# of Institutions

153

Shares Held

164M

Call Options Held

1.11M

Put Options Held

36.8K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $275M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account